Hormonal Treatment and Depression

Past research has demonstrated a link between traditional prostate cancer hormone therapy (HT) and the risk of depression among prostate cancer patients.

A retrospective clinical trial investigated whether second-generation antiandrogens (AAs) are also associated with increased risk of depression.

Three treatments were compared during the study: no HT, traditional HT, and second-generation AA.

Results indicate that patients receiving a second-generation AA had an increased risk of depression compared with traditional HT alone or no HT.

These findings emphasize the need for emotional distress monitoring and the implantation of focused interventions to alleviate symptoms among these patients.

For more info:


This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service or treatment.

More Articles

Meet Dave

Watch the worlds first AI oncology mentor. Intelligent and informative. Proactive and experienced. Available 24/7….

Hyperacusis and Multiple Sclerosis

Living with multiple sclerosis (MS) can be challenging, affecting various aspects of daily life. But…

Alcohol and MS

One topic that often comes up is the relationship between alcohol consumption and MS.In this…

The Healing Power of Music

How Songs Can Lift Your Spirits Music has a unique way of touching our souls…

Keeping the Flame Alive

By Lizzie Rubin, a certified sex therapist. Navigating Intimacy During the Summer Heat with Multiple…

Boiling Point

According to oncologists, anger is one of the first emotions patients express upon diagnosis. That…
Skip to content